OrganOx has raised £25m to continue the development and commercial rollout of metra, its fully automated normothermic perfusion (NMP) device for liver transplantation.
The round was led by external investor Lauxera Capital Partners, with support from existing investors.
Caristo Diagnostics has raised £13m to advance its CaRi-Heart® technology, an AI-assisted heart imaging tool capable of predicting risk of future heart attacks.
The round was led by Oxford Science Enterprises with participation from BGF, Longwall Venture Partners and Oxford University.
Mind Foundry, an Oxford University spinout that develops AI for high-stakes applications, has announced a continuation of their successful collaboration with the Aioi Nissay Dowa group.
The Aioi R&D Lab will focus on developing real-world AI solutions to major societal challenges through better insurance.
Living Optics, an Oxford-based imaging company, has closed a £20m Series A financing led by Octopus Ventures, one of UK’s leading VC firms, alongside support from existing investors.
The investment will be used to further scale the team as the company builds on its position as a record holder in many of the most important computational imaging metrics.
